LAWRENCE M LITTELL

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Pain Medicine WATERTOWN, NY NPI 1295792893

General Payments — all program years on this page

$1,478.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $243.20 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $243.2017

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ITI, Inc. $213.6516
Vanda Pharmaceuticals Inc. $29.551

By program year

Program yearAmountRecords
2018 $151.7414
2019 $109.579
2020 $231.9914
2021 $303.5916
2022 $312.7323
2023 $125.197
2024 $243.2017

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1133910516 Vanda Pharmaceuticals Inc. $29.55 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266222 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.91 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266225 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.63 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266229 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.63 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266232 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.02 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266236 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.73 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266240 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.67 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266243 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.91 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266247 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.67 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266250 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.73 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266254 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.23 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266258 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.00 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266261 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.23 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266265 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.99 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266269 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.73 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266272 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.34 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266276 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.23 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.